Photodynamic diagnosis of non–muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

M Burger, HB Grossman, M Droller, J Schmidbauer… - European urology, 2013 - Elsevier
Background Studies on hexaminolevulinate (HAL) cystoscopy report improved detection of
bladder tumours. However, recent meta-analyses report conflicting effects on recurrence …

Hexyl aminolevulinate–guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non–muscle-invasive bladder cancer: a critical review of the …

M Rink, M Babjuk, JWF Catto, P Jichlinski, SF Shariat… - European urology, 2013 - Elsevier
Context Controversy exists regarding the therapeutic benefit and cost effectiveness of
photodynamic diagnosis (PDD) with 5-aminolevulinic acid (5-ALA) or hexyl aminolevulinate …

Bladder cancer survivorship

SK Bhanvadia - Current urology reports, 2018 - Springer
Abstract Purpose of Review Bladder cancer (BC) is the second most common genitourinary
malignancy, with a growing population of survivors globally. Over the past two decades …

Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy

HB Grossman, A Stenzl, Y Fradet… - The Journal of …, 2012 - auajournals.org
Purpose: We assessed the impact of hexaminolevulinate fluorescence cystoscopic detection
of papillary, nonmuscle invasive bladder cancer on the long-term recurrence rate. Materials …

Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: systematic review …

R Chou, S Selph, DI Buckley, R Fu, JC Griffin… - The Journal of …, 2017 - Elsevier
Purpose We systematically reviewed the comparative effectiveness of fluorescent vs white
light cystoscopy on bladder cancer clinical outcomes. Materials and Methods Systematic …

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use …

Y Lotan, TJ Bivalacqua, T Downs, W Huang… - Nature Reviews …, 2019 - nature.com
Blue light cystoscopy (BLC) with hexaminolevulinate (HAL) during transurethral resection of
bladder cancer improves detection of non-muscle-invasive bladder cancer (NMIBC) and …

[HTML][HTML] Time to turn on the blue lights: a systematic review and meta-analysis of photodynamic diagnosis for bladder cancer

R Veeratterapillay, P Gravestock, A Nambiar… - European urology open …, 2021 - Elsevier
Context White light (WL) cystoscopy and transurethral resection of bladder tumour (TURBT)
comprise the current gold standard technique for detecting and grading bladder cancer …

[HTML][HTML] CUA guidelines on the management of non-muscle invasive bladder cancer

W Kassouf, SL Traboulsi, GS Kulkarni… - Canadian Urological …, 2015 - ncbi.nlm.nih.gov
Methods We update the previously published 2009 Canadian guidelines on the
management of NMIBC, emphasizing intravesical therapy. 18 We conducted a …

Oncological outcomes of sequential intravesical gemcitabine and docetaxel in patients with non-muscle invasive bladder cancer

N Milbar, M Kates, MR Chappidi, F Pederzoli… - Bladder …, 2017 - content.iospress.com
Background: Bacillus Calmette-Guérin (BCG) unresponsive/relapsing patients with non-
muscle invasive bladder cancer (NMIBC) who prefer bladder preservation over radical …

A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5 …

JY Lee, KS Cho, DH Kang, HD Jung, JK Kwon, CK Oh… - BMC cancer, 2015 - Springer
Background This study included a network meta-analysis of evidence from randomized
controlled trials (RCTs) to assess the therapeutic outcome of transurethral resection (TUR) in …